CoChat

Linezolid for the treatment of patients with endocarditis: a systematic review of the published evidence

Falagas, M. E. · 2006 · Journal of Antimicrobial Chemotherapy

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Abstract

Background Linezolid is a bacteriostatic oxazolidinone antibiotic that has been proven to be effective for the treatment of patients with pneumonia, skin and soft tissue infections, and possibly bacteraemia, due to Gram-positive cocci. However, the drug is sometimes used for the treatment of patients with endocarditis due to Gram-positive cocci resistant to other antibiotics. Methods We carried out a review of the available literature to evaluate whether linezolid is also effective for the treatment of patients with infective endocarditis. Results We identified 23 case reports and 3 case series reporting the experience with 56 patients with endocarditis treated with linezolid. Evaluable data for 33 patients who received linezolid and for whom individual patient data were reported were further analysed. Prosthetic valve infective endocarditis accounted for 25% of the reviewed cases. Methicillin-resistant Staphylococcus aureus and vancomycin-intermediate S. aureus were the most commonly isolated cocci (24.2% and 30.3% of cases, respectively). Linezolid alone was administered to 66.7% of patients while the rest received the antibiotic in combination with rifampicin, gentamicin, fusidic acid or amikacin. A total of 63.6% (21/33) of patients with endocarditis were cured after linezolid administration. The overall and endocarditis-related mortality was 33.3% (11/33) and 12.1% (4/33), respectively. Thrombocytopenia developed in 30.8% (8/26) of patients for whom relevant data were av…

Overview

Integrity signals

Registry

Crossref · 10.1093/jac/dkl219

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 43 references

Cited by

See all 167

Metadata

Authors
Falagas, M. E.
Affiliations
Henry Dunant Hospital (GR)
Corresponding author
Falagas, M. E.
Venue
Journal of Antimicrobial Chemotherapy
Published
2006-05-30
Volume
58
Issue
2
Pages
273-280
ISSN
  • 0305-7453 (ISSN-L)
  • 1460-2091
OpenAlex
W2132751055
Cited by
167
References
43
Citations by year
2026: 2 · 2025: 4 · 2024: 4 · 2023: 10 · 2022: 1 · 2021: 2 · 2020: 4 · 2019: 6 · 2018: 4 · 2017: 6 · 2016: 4 · 2015: 12 · 2014: 11 · 2013: 3 · 2012: 10
FWCI
2.06
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Antimicrobial Chemotherapy (publishedVersion)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
  • Health Sciences › Medicine › Surgery › Orthopedic Infections and Treatments
  • Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
Keywords
linezolid, infective endocarditis, oxazolidinones, methicillin-resistant Staphylococcus aureus, vancomycin-intermediate Staphylococcus aureus, prosthetic valve endocarditis, bacteriostatic antibiotics, treatment efficacy, mortality, thrombocytopenia, combination antibiotic therapy
MeSH terms
Linezolid, Acetamides, Anti-Bacterial Agents, Endocarditis, Bacterial, Humans, Gram-Positive Bacterial Infections, Oxazolidinones

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Linezolid for the treatment of patients with endocarditis: a systematic review of the published evidence. https://app.cochat.ai/papers/10.1093/jac/dkl219
The paper
Falagas, M. E. (2006). Linezolid for the treatment of patients with endocarditis: a systematic review of the published evidence. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkl219

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.